Project Grant R01AG098480
Award Date 4/15/26
Completion Date 3/31/31
Dollars Obligated $763K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $2.59M Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded September 15, 2025, with completion targeted for August 31, 2029. The research project aims to elucidate mechanisms of adipocyte-brain communication and their impact on glial function, neuroprotection, and brain aging, with potential implications for preventing dementia and age-related cognitive decline. The...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant totaling $132,705.00 on June 15, 2025, to The Children's Hospital Corporation (Boston Children's Hospital) under the Aging Research program (CFDA 93.866). This award supports research addressing hematopoietic clonal dominance during aging—a condition in which driver mutations cause a limited number of hematopoietic stem and progenitor cell (HSPC) clones to disproportionately contribute to blood cell...
- Federal Grant Award Summary The National Institute on Aging awarded The Washington University a $1,746,856 Project Grant under the Aging Research program (CFDA 93.866) on August 5, 2025, with a completion date of April 30, 2030. The grant funds research investigating the role of senescent cancer-associated fibroblasts (SENCAFs) in breast cancer progression, with particular emphasis on age-related changes in the tumor microenvironment. The research addresses a significant public health need, as...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of Pittsburgh a $3.1 million Project Grant under the Aging Research program (CFDA 93.866) for the period September 1, 2025, through August 31, 2029. This research project investigates the mechanistic link between persistent DNA damage and the immune response pathway in aging and DNA repair-deficient conditions. The award supports biomedical research directed toward understanding how the NLRP12 (NOD-like...
- Federal Project Grant Summary The National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), awarded $393,750 to the University of California, Los Angeles on September 22, 2025, to conduct a prospective cohort study evaluating the impact of gastroesophageal cancer (GEC) treatments on physical function in older adults aged 60 years and above. The research project, with completion scheduled for August 31, 2027, will deliver scientific evidence through serial geriatric...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Pennsylvania $243,000 under the Aging Research program (CFDA 93.866) on September 5, 2025, with a completion date of May 31, 2030. This project grant supports research investigating the impact of frailty on disease relapse and therapy intensity in older adults with acute myeloid leukemia (AML), with particular focus on identifying biomarkers and optimizing treatment selection. The research...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of Miami a Project Grant totaling $109,652.00 under the Aging Research program (CFDA 93.866) on September 5, 2026, with a completion date of September 4, 2027. This award supports research investigating T cell senescence-driven immune dysfunction in aging and HIV-positive populations. The research project aims to elucidate the mechanisms by which senescent T cells—cells that have undergone stable cell...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded The Washington University a $1,080,528 Project Grant effective June 1, 2025, through March 31, 2030, under the Aging Research program (CFDA 93.866). This grant supports fundamental research investigating the mechanisms by which senescent stromal cells drive chemotherapy-induced peripheral neuropathy (CIPN), a debilitating condition affecting up to 90% of cancer patients receiving taxane chemotherapy, with 30%...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Icahn School of Medicine at Mount Sinai a Project Grant of $463,625 under the Aging Research program (CFDA 93.866) to conduct biomedical research on lung adenocarcinoma (LUAD) and its relationship to patient age. The award, which commenced September 1, 2025, and extends through August 31, 2027, funds research to understand how aging affects the LUAD tumor microenvironment (TME) and to identify therapeutic...
- Federal Project Grant Award Summary The National Cancer Institute awarded a Project Grant of $399,852.00 to the Regents of the University of Minnesota under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period May 1, 2026, through April 30, 2028. This research initiative will develop and validate circulating senescent-associated secretory phenotype (SASP) protein indexes to assess accelerated aging in cancer survivors. The primary deliverable involves creating...